Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:54 PM
Ignite Modification Date:
2025-12-24 @ 10:54 PM
NCT ID:
NCT04485169
Eligibility Criteria:
Inclusion Criteria:
* COVID-19 diagnosed by Polymerase Chain Reaction (PCR) positivity for SARS-CoV2
* CRS at presentation or developing during hospitalization
* 10-80 years age and both genders
* hospital admission
* At least 1 completed session of plasma-exchange in patients included in TPE arm
* No other novel therapy administered.
Exclusion criteria were:
* Death within 48 hours of admission
* severe septic shock at time of admission
* Congestive cardiac failure (EF\<20%) (4)
* Those receiving immunotherapy, Anti-thymocyte globulin or hematopoietic stem cell transplant in recent past
* Patients of hematological or solid organ malignancies
* patients receiving other investigational drugs including Tocilizumab, Convalescent plasma, Remdesivir, or Mesenchymal stem cells.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT04485169
Study Brief:
Protocol Section:
NCT04485169